Cooper C L, Malik K U
J Pharmacol Exp Ther. 1986 Feb;236(2):424-31.
We have investigated the contribution of Ca++ and calmodulin to the action of norepinephrine (NE) on prostaglandin (PG) synthesis and vascular tone in the Tyrode's perfused rat kidney. Lowering the Ca++ concentration (0.6 mM) reduced and raising the Ca++ concentration (5.4 mM) enhanced the renal vasoconstriction and PG output elicited by NE. Calcium channel blockers diltiazem or nimodipine inhibited the vasoconstriction and PG output caused by NE. Ca++-free Tyrode's solution containing ethylene glycol bis(beta-aminoethyl ether)-N,N'-tetraacetic acid abolished NE-induced vasoconstriction and reduced PG output by 25 to 38%. Addition of intracellular Ca++ antagonists 8-(diethylamino) octyl 3,4,5 trimethoxybenzoate, dantrolene or ryanodine to Ca++-free Tyrode's solution inhibited NE-induced PG output. Calmodulin inhibitors trifluoperazine, N-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide or calmidazolium diminished PG output and the renal vasoconstriction elicited by NE in the presence and absence of Ca++. Mepacrine and indomethacin inhibited NE-induced renal vasoconstriction and PG output. Arachidonic acid-induced PG output was abolished by indomethacin but was unaltered by mepacrine, Ca++ antagonists or calmodulin inhibitors. We conclude that NE produces renal vasoconstriction by a mechanism that depends primarily on extracellular Ca++ and calmodulin, whereas NE-induced PG output depends on both extra- and intracellular Ca++ and calmodulin.
我们研究了钙离子(Ca++)和钙调蛋白对去甲肾上腺素(NE)作用于台氏液灌注的大鼠肾脏中前列腺素(PG)合成及血管张力的影响。降低Ca++浓度(0.6 mM)可减轻,而升高Ca++浓度(5.4 mM)则增强NE引起的肾血管收缩和PG释放。钙通道阻滞剂地尔硫䓬或尼莫地平可抑制NE引起的血管收缩和PG释放。含乙二醇双(β-氨基乙基醚)-N,N'-四乙酸的无钙台氏液可消除NE诱导的血管收缩,并使PG释放减少25%至38%。向无钙台氏液中添加细胞内Ca++拮抗剂8-(二乙氨基)辛基3,4,5-三甲氧基苯甲酸酯、丹曲林或ryanodine可抑制NE诱导的PG释放。钙调蛋白抑制剂三氟拉嗪、N-(6-氨基己基)-5-氯-1-萘磺酰胺或氯米达唑在有或无Ca++的情况下,均可减少NE引起的PG释放和肾血管收缩。氯喹和吲哚美辛可抑制NE诱导的肾血管收缩和PG释放。吲哚美辛可消除花生四烯酸诱导的PG释放,但氯喹、Ca++拮抗剂或钙调蛋白抑制剂对其无影响。我们得出结论,NE通过一种主要依赖细胞外Ca++和钙调蛋白的机制产生肾血管收缩,而NE诱导的PG释放则依赖细胞外和细胞内的Ca++及钙调蛋白。